NCT00335075 Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644) Status COMPLETED Phase PHASE3
NCT00323115 Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00316849 Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT00311857 Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) Status UNKNOWN Phase PHASE1/PHASE2
NCT00311584 Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma Status COMPLETED Phase PHASE2
NCT00305864 Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Status COMPLETED Phase PHASE1/PHASE2
NCT00303940 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors Status COMPLETED Phase PHASE1
NCT00302159 Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors Status COMPLETED Phase PHASE2
NCT00301067 Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00283543 Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma Status UNKNOWN Phase PHASE2
NCT00276679 Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma Status COMPLETED Phase PHASE2
NCT00275067 Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery Status UNKNOWN Phase PHASE1/PHASE2
NCT00275002 O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors Status COMPLETED Phase PHASE2
NCT00274833 Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00272415 A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma Status TERMINATED Phase PHASE1
NCT00268385 Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00262730 Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM Status COMPLETED Phase PHASE2
NCT00257205 CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy Status COMPLETED Phase PHASE3
NCT00253487 Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas Status COMPLETED Phase NA